NorthSea Therapeutics: Funding, Investors & Team (Sep 2026)
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics. The team leverages Structurally Engineered Fatty Acid (SEFA) technology to develop novel and unique therapeutic approaches targeting metabolic, inflammatory and fibrotic diseases. The SEFA technology has generated pipeline candidates with a broad array of inter- and independent biological effects, improving dyslipidemia, insulin resistance, hepatic inflammation and fibrosis in diverse models.
NorthSea Therapeutics has raised $80.0M across 1 funding round on record, the most recent a Series C of $80.0M announced in Dec 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NorthSea Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2021.
NorthSea Therapeutics Funding Rounds
NorthSea Therapeutics Founders and Leadership Team
Contact details for the NorthSea Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →NorthSea Therapeutics Funding Compared to Other Biotechnology Startups
NorthSea Therapeutics' latest round of $80.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NorthSea Therapeutics in Biotechnology and Naarden
Companies Similar to NorthSea Therapeutics
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
NorthSea Therapeutics Funding FAQs
What does NorthSea Therapeutics do?
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics. The team leverages Structurally Engineered Fatty Acid (SEFA) technology to develop novel and unique therapeutic approaches targeting metabolic, inflammatory and fibrotic diseases. The SEFA technology has generated pipeline candidates with a broad array of inter- and independent biological effects, improving dyslipidemia, insulin resistance, hepatic inflammation and fibrosis in diverse models.
How much funding has NorthSea Therapeutics raised?
NorthSea Therapeutics has raised $80.0M across 1 round on record. The most recent is a Series C of $80.0M announced in Dec 2021.
When did NorthSea Therapeutics last raise funding?
NorthSea Therapeutics' most recent funding round on record is a Series C of $80.0M, announced in Dec 2021.
Who is the CEO of NorthSea Therapeutics?
Rob de Ree is listed as CEO at NorthSea Therapeutics.
Where is NorthSea Therapeutics headquartered?
NorthSea Therapeutics is based in Naarden, Noord-Holland, Netherlands.
How many employees does NorthSea Therapeutics have?
NorthSea Therapeutics is in the 11-50 employee band.
How does NorthSea Therapeutics' funding compare to other Biotechnology startups?
NorthSea Therapeutics' latest round of $80.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's NorthSea Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NorthSea Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.